Sigma Healthcare (SIG.AX) Stock Price

Sigma Healthcare Price

ASX·CLOSED
2.89AUD-0.0100 (-0.35 %)
Market closed

Revenue has compounded at 4.2% per year over the past 19 years to 6.00 B AUD. Earnings per share have declined at 3.6% per year over the last 19 years. Sigma Healthcare's net margin stands at 8.8%, up from -0.2% several years earlier. Sigma Healthcare currently offers a dividend yield of about 0.64%. The payout ratio is around 37% of earnings. Analysts set a median price target of 3.46 AUD, implying 19.6% above the current price. Of 17 analysts, 12 rate the stock a buy — an overall Buy consensus. The stock trades about 11% above its 52-week low.

Sigma Healthcare stock price

Volume
Ex-Dividend
Details

Stock Price

ⓘ

How to Read This Chart

This chart tracks the historical stock price of Sigma Healthcare over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Sigma Healthcare stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Sigma Healthcare's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

Sigma Healthcare Stock Price History
DateSigma Healthcare Price
7/22/20262.89 AUD
7/21/20262.90 AUD
7/20/20262.93 AUD
7/17/20262.93 AUD
7/16/20262.94 AUD
7/15/20262.94 AUD
7/14/20262.92 AUD
7/13/20262.90 AUD
7/10/20262.80 AUD
7/9/20262.87 AUD
7/8/20262.80 AUD
7/7/20262.82 AUD
7/6/20262.82 AUD
7/3/20262.79 AUD
7/2/20262.71 AUD
7/1/20262.76 AUD
6/30/20262.76 AUD
6/29/20262.78 AUD
6/26/20262.78 AUD
6/25/20262.79 AUD
6/24/20262.74 AUD
6/23/20262.74 AUD
6/22/20262.76 AUD
6/19/20262.77 AUD
6/18/20262.82 AUD
6/17/20262.82 AUD
6/16/20262.81 AUD
6/15/20262.82 AUD
6/12/20262.66 AUD
6/11/20262.71 AUD
6/10/20262.76 AUD
6/9/20262.92 AUD
6/5/20262.92 AUD
6/4/20262.90 AUD
6/3/20262.89 AUD
6/2/20262.82 AUD
6/1/20262.92 AUD
5/29/20262.91 AUD
5/28/20262.85 AUD
5/27/20262.85 AUD
5/26/20262.87 AUD
5/25/20262.87 AUD
5/22/20262.87 AUD
5/21/20262.87 AUD
5/20/20262.87 AUD
5/19/20262.85 AUD
5/18/20262.82 AUD
5/15/20262.86 AUD
5/14/20262.86 AUD
5/13/20262.86 AUD
5/12/20262.85 AUD
5/11/20262.84 AUD
5/8/20262.85 AUD
5/7/20262.89 AUD
5/6/20262.92 AUD
5/5/20262.92 AUD
5/4/20262.83 AUD
5/1/20262.81 AUD
4/30/20262.79 AUD
4/29/20262.78 AUD
4/28/20262.75 AUD
4/27/20262.77 AUD
4/24/20262.79 AUD
4/23/20262.81 AUD
4/22/20262.82 AUD
4/21/20262.84 AUD
4/20/20262.78 AUD
4/17/20262.80 AUD
4/16/20262.74 AUD
4/15/20262.70 AUD
4/14/20262.71 AUD
4/13/20262.67 AUD
4/10/20262.69 AUD
4/9/20262.70 AUD
4/8/20262.70 AUD
4/7/20262.67 AUD
4/2/20262.66 AUD
4/1/20262.73 AUD
3/31/20262.65 AUD
3/30/20262.66 AUD
3/27/20262.62 AUD
3/26/20262.62 AUD
3/25/20262.65 AUD
3/24/20262.60 AUD
3/23/20262.67 AUD
3/20/20262.78 AUD
3/19/20262.66 AUD
3/18/20262.68 AUD
3/17/20262.66 AUD
3/16/20262.69 AUD
3/13/20262.64 AUD
3/12/20262.66 AUD
3/11/20262.71 AUD
3/10/20262.74 AUD
3/9/20262.73 AUD
3/6/20262.85 AUD
3/5/20262.80 AUD
2/26/20262.94 AUD
2/25/20262.99 AUD
2/24/20263.00 AUD
2/23/20262.97 AUD
2/20/20262.94 AUD
2/19/20262.98 AUD
2/18/20262.99 AUD
2/17/20263.02 AUD
2/16/20263.01 AUD
2/13/20263.03 AUD
2/12/20263.04 AUD
2/11/20263.09 AUD
2/10/20263.09 AUD
2/9/20263.12 AUD
2/6/20263.13 AUD
2/5/20263.16 AUD
2/4/20263.16 AUD
2/3/20263.14 AUD
2/2/20263.10 AUD
1/30/20263.09 AUD
1/29/20263.09 AUD
1/28/20263.08 AUD
1/27/20263.09 AUD
1/23/20263.06 AUD
1/21/20262.90 AUD
1/20/20262.92 AUD
1/19/20262.87 AUD
1/16/20262.91 AUD
1/15/20262.85 AUD
1/14/20262.85 AUD
1/13/20262.91 AUD
1/12/20262.92 AUD
1/9/20262.89 AUD
1/8/20262.89 AUD
1/7/20262.87 AUD
1/6/20262.83 AUD
1/5/20262.92 AUD
1/2/20262.94 AUD
12/31/20252.95 AUD
12/30/20252.97 AUD
12/29/20252.97 AUD
12/24/20252.98 AUD
12/23/20252.97 AUD
12/22/20252.95 AUD
12/19/20253.00 AUD
12/18/20252.90 AUD
12/17/20252.94 AUD
12/16/20252.97 AUD
12/15/20252.91 AUD
12/12/20252.92 AUD
12/11/20252.90 AUD
12/10/20252.85 AUD
12/9/20252.85 AUD
12/8/20252.81 AUD
12/5/20252.85 AUD
12/4/20252.76 AUD
12/3/20252.80 AUD
12/2/20252.84 AUD
12/1/20252.84 AUD
11/28/20252.88 AUD
11/27/20252.89 AUD
11/26/20252.92 AUD
11/25/20252.91 AUD
11/24/20252.93 AUD
11/21/20252.95 AUD
11/20/20252.94 AUD
11/19/20252.92 AUD
11/18/20252.92 AUD
11/17/20252.93 AUD
11/14/20252.96 AUD
11/13/20253.07 AUD
11/12/20253.13 AUD
11/11/20253.15 AUD
11/10/20253.12 AUD
11/7/20253.11 AUD
11/6/20253.11 AUD
11/5/20253.12 AUD
11/4/20253.10 AUD
11/3/20253.10 AUD
10/31/20253.12 AUD
10/30/20253.11 AUD
10/29/20253.10 AUD
10/28/20253.09 AUD
10/27/20253.08 AUD
10/24/20253.10 AUD
10/23/20253.11 AUD
10/22/20253.06 AUD
10/21/20253.04 AUD
10/20/20252.97 AUD
10/17/20253.03 AUD
10/15/20253.00 AUD
10/14/20253.01 AUD
10/13/20253.03 AUD
10/10/20253.02 AUD
10/9/20253.02 AUD
10/8/20252.93 AUD
10/7/20252.90 AUD
10/6/20252.95 AUD
10/3/20252.99 AUD
10/2/20253.02 AUD
10/1/20252.97 AUD
9/30/20252.97 AUD
9/29/20253.01 AUD
9/26/20253.01 AUD
9/25/20253.01 AUD
9/24/20253.04 AUD
9/23/20253.05 AUD
9/22/20253.04 AUD
9/19/20252.99 AUD
9/17/20252.99 AUD
9/16/20253.01 AUD
9/15/20253.00 AUD
9/12/20252.99 AUD
9/11/20252.99 AUD
9/10/20252.99 AUD
9/9/20253.01 AUD
9/8/20253.04 AUD
9/5/20253.04 AUD
9/4/20253.05 AUD
9/3/20253.08 AUD
9/2/20253.09 AUD
9/1/20253.12 AUD
8/29/20253.12 AUD
8/28/20253.09 AUD
8/27/20253.03 AUD
8/26/20252.81 AUD
8/25/20252.88 AUD
8/22/20252.85 AUD
8/21/20252.85 AUD
8/20/20252.82 AUD
8/19/20252.83 AUD
8/18/20252.87 AUD
8/15/20252.84 AUD
8/14/20252.86 AUD
8/13/20252.86 AUD
8/12/20252.86 AUD
8/11/20252.84 AUD
8/8/20252.86 AUD
8/7/20252.87 AUD
8/6/20252.88 AUD
8/5/20252.89 AUD
8/4/20252.87 AUD
8/1/20252.85 AUD
7/31/20252.89 AUD
7/30/20252.93 AUD
7/29/20252.89 AUD
7/28/20252.90 AUD
Access this data via the Eulerpool API
Get Free API Key

Sigma Healthcare Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2023
3.42 B AUD
23.20 M AUD
4.51 M AUD
Jan 1, 2024
4.93 B AUD
21.66 M AUD
-13.84 M AUD
Jan 1, 2025
6.00 B AUD
737.67 M AUD
529.91 M AUD
Jan 1, 2026 (e)
10.72 B AUD
1.10 B AUD
679.55 M AUD
Jan 1, 2027 (e)
11.81 B AUD
1.29 B AUD
805.68 M AUD
Jan 1, 2028 (e)
12.86 B AUD
1.49 B AUD
921.32 M AUD
Jan 1, 2029 (e)
12.56 B AUD
1.61 B AUD
1.01 B AUD
Jan 1, 2030 (e)
13.42 B AUD
1.79 B AUD
1.13 B AUD

Sigma Healthcare Income Statement, Balance Sheet, Cash Flow Statement

Last updated Jul 25, 2026, 9:38 AM
 
REVENUEB AUD
REVENUE GROWTH%
GROSS MARGIN%
GROSS INCOMEB AUD
EBITB AUD
EBIT MARGIN%
NET INCOMEB AUD
NET INCOME GROWTH%
DIV.AUD
DIV. GROWTH%
SHARESB
20162017201820192020202120222023202420252026e2027e2028e2029e2030e2031e
4.444.214.083.343.513.553.763.424.936.0010.7211.8112.8612.5613.4214.32
25.83-5.20-3.25-17.964.971.145.97-9.1544.1321.8578.6010.178.93-2.396.926.67
8.248.719.109.399.929.619.479.167.4124.0024.0024.0024.0024.0024.0024.00
0.370.370.370.310.350.340.360.310.371.442.572.833.093.013.223.44
0.090.080.06–0.01–0.030.020.020.741.101.291.491.611.79–
2.071.971.50-0.030.280.080.850.670.4312.2810.2510.8811.5612.8213.33–
0.050.060.04-0.010.04-0.01––-0.010.530.680.810.921.011.131.15
6.003.77-34.55-133.33-458.33-116.28-114.29300.00-425.00-4,169.2328.3618.5614.419.4511.612.58
0.080.070.060.040.040.030.030.010.010.020.040.040.04–––
33.33-12.50-14.29-33.33–-25.00–-66.67–100.00100.00–––––
1.071.051.010.971.051.021.051.061.5710.4910.4910.4910.4910.4910.4910.49
Details

Income Statement Key Figures

ⓘ

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales Sigma Healthcare generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Sigma Healthcare retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Sigma Healthcare's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares Sigma Healthcare has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Sigma Healthcare's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

Sigma Healthcare stock margins

The Sigma Healthcare margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Sigma Healthcare. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Sigma Healthcare.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2021
9.61 %
0.11 %
-0.20 %
Jan 1, 2022
9.47 %
0.87 %
0.05 %
Jan 1, 2023
9.17 %
0.68 %
0.13 %
Jan 1, 2024
7.43 %
0.44 %
-0.28 %
Jan 1, 2025
24.00 %
12.29 %
8.83 %
Jan 1, 2026 (e)
24.00 %
10.25 %
6.34 %
Jan 1, 2027 (e)
24.00 %
10.88 %
6.82 %
Jan 1, 2028 (e)
24.00 %
11.56 %
7.16 %

Sigma Healthcare Stock Revenue, EBIT, Earnings per Share

The Sigma Healthcare earnings per share therefore indicates how much revenue Sigma Healthcare has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
EBIT per share
Earnings per Share
Details
Date
Revenue per Share
EBIT per share
Earnings per Share
Jan 1, 2021
3.49 AUD
0.00 AUD
-0.01 AUD
Jan 1, 2022
3.60 AUD
0.03 AUD
0.00 AUD
Jan 1, 2023
3.21 AUD
0.02 AUD
0.00 AUD
Jan 1, 2024
3.13 AUD
0.01 AUD
-0.01 AUD
Jan 1, 2025
0.57 AUD
0.07 AUD
0.05 AUD
Jan 1, 2026 (e)
1.02 AUD
0.10 AUD
0.06 AUD
Jan 1, 2027 (e)
1.13 AUD
0.12 AUD
0.08 AUD
Jan 1, 2028 (e)
1.23 AUD
0.14 AUD
0.09 AUD

Sigma Healthcare business model & stock analysis

Sigma Healthcare Ltd is an Australian company that has been operating in the healthcare industry for over 100 years. Founded in 1911 as a local pharmacy in Melbourne, the company has since become a leading provider of pharmaceutical services in Australia. The company's core business is the delivery of pharmacy products and services to pharmacies and medical practices across Australia. Sigma Healthcare Ltd supplies over 4,000 independent retailers as well as numerous large chains and department store pharmacies. Sigma Healthcare Ltd also offers various healthcare services, such as consulting, training, and support in medication delivery. Divided into different divisions, Sigma Healthcare Ltd offers a wide portfolio of products. In the pharmaceutical products division, the company distributes national and international medications, both prescription and over-the-counter. Additionally, health and personal care products such as medical devices, supplements, vitamins, and minerals are available. The general products division offers a variety of non-food products, such as personal care products, wellness products, hygiene products, cleaning agents, cosmetics, and household products. Another important division is the pharmacy management system, which supports pharmacies in managing their business and billing processes. The system complements the existing offering with additional features, such as inventory management, prescription processing, accounting, and customer loyalty. Innovation plays a central role at Sigma Healthcare Ltd. The company invests significant resources in researching and developing new products and services to continuously improve the customer experience and meet the ever-growing demands of the industry. The company benefits from close relationships with leading manufacturers and international organizations. Partnerships are another crucial aspect of Sigma Healthcare Ltd's business model. The company works closely with manufacturers, retailers, pharmacists, and other partners to jointly create innovative solutions and products to enhance the customer experience. In recent years, Sigma Healthcare Ltd has also pursued a significant growth strategy, such as acquiring companies that complement its existing portfolio. This includes the acquisition of API in 2020 and Discount Drug Stores in 2018, which have greatly expanded the offerings of Sigma Healthcare Ltd. Overall, Sigma Healthcare Ltd is an important company in the Australian healthcare industry. With a wide range of products and services, a strong culture of innovation, and significant partnerships with industry players, the company will continue to establish itself as a key player in healthcare and continuously improve the customer experience.

Sigma Healthcare SWOT Analysis

Strengths

1. Strong market presence: Sigma Healthcare Ltd has established itself as a leading player in the healthcare industry.

2. Diverse product portfolio: The company offers a wide range of pharmaceutical and medical products, catering to various customer needs.

3. Strategic partnerships: Sigma Healthcare has forged strong partnerships with major suppliers, enabling them to access a diverse range of products and deliver value to customers.

4. Broad distribution network: The company has an extensive distribution network that ensures efficient and timely delivery of products to pharmacies and hospitals.

5. Strong financial position: Sigma Healthcare enjoys a stable financial position, which provides them with the resources to invest in growth opportunities and innovation.

Weaknesses

1. Dependence on suppliers: Sigma Healthcare heavily relies on its suppliers for the availability of products, which exposes them to potential supply chain disruptions.

2. Vulnerability to regulatory changes: The company operates in a highly regulated industry, making it susceptible to changes in government policies and regulations.

3. Limited international presence: While Sigma Healthcare has a strong presence within the domestic market, their international reach is limited, potentially hindering expansion into global markets.

4. Competitive market: The healthcare industry is highly competitive, and Sigma Healthcare faces competition from both traditional and online pharmacies, which could impact market share.

Opportunities

1. Growing healthcare industry: With the increasing demand for healthcare products and services, Sigma Healthcare can capitalize on this opportunity to expand its customer base and market share.

2. Technological advancements: The adoption of digital technologies in the healthcare sector opens up avenues for Sigma Healthcare to enhance operational efficiency and improve customer experience.

3. Expansion into emerging markets: Exploring and entering emerging markets can provide Sigma Healthcare with new growth opportunities and access to a larger customer base.

Threats

1. Economic fluctuations: Sigma Healthcare may be affected by economic downturns, which could impact consumer spending on healthcare products and services.

2. Price competition: The presence of low-cost competitors within the industry may put pressure on Sigma Healthcare's pricing strategy.

3. Technological disruption: Rapid advancements in technology may disrupt traditional distribution models, requiring Sigma Healthcare to adapt and invest in new systems and infrastructure.

4. Regulatory challenges: Tightening of regulations or changes in government policies can impose compliance burdens on Sigma Healthcare and increase operational costs.

Sigma Healthcare Eulerpool Fair Value

Details

Fair Value Estimate

ⓘ

What Is Fair Value?

Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.

Earnings-Based Fair Value

Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.

Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021

Revenue-Based Fair Value

Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"

Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021

Dividend-Based Fair Value

Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.

Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021

How to Use This Chart

When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.

Sigma Healthcare historical P/E ratio, EBIT multiple, and P/S ratio

Sigma Healthcare annual returns

Details

Annual Return

ⓘ

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

Sigma Healthcare shares outstanding

The number of shares of Sigma Healthcare was 10.49 B in 2025. This indicates how many shares Sigma Healthcare is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2021
1.02 B Stocks
Jan 1, 2022
1.05 B Stocks
Jan 1, 2023
1.06 B Stocks
Jan 1, 2024
1.57 B Stocks
Jan 1, 2025
10.49 B Stocks
Jan 1, 2026 (e)
10.49 B Stocks
Jan 1, 2027 (e)
10.49 B Stocks
Jan 1, 2028 (e)
10.49 B Stocks

Sigma Healthcare stock splits

In Sigma Healthcare's history, there have been no stock splits.

Sigma Healthcare Dividend History

22 years of dividend payments

YearAnnual DividendYoY ChangePayments
20250.02AUD↑ 67.7%1×
Sep 2, 20250.02AUD↑ 271.4%1/1
20240.01AUD↓ 22.5%2×
20230.01AUD↓ 33.3%2×
20220.02AUD↓ 25.0%2×
20210.03AUD↓ 33.3%2×
20200.04AUD↑ 0.0%—
20190.04AUD↓ 25.0%2×
20180.06AUD↓ 27.3%2×
20170.08AUD 0.0%2×
20160.08AUD↑ 37.5%2×

Sigma Healthcare dividend history and estimates

In 2025, Sigma Healthcare paid a dividend amounting to 0.02 AUD. Dividend means that Sigma Healthcare distributes a portion of its profits to its owners.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Dividend
Dividend (Estimate)
Details
Date
Dividend
Dividend (Estimate)
Special dividend
Jan 1, 2021 (e)
0.03 AUD
0.00 AUD
0.00 AUD
Jan 1, 2022 (e)
0.02 AUD
0.01 AUD
0.00 AUD
Jan 1, 2023
0.01 AUD
0.00 AUD
0.00 AUD
Jan 1, 2024
0.01 AUD
0.00 AUD
0.00 AUD
Jan 1, 2025
0.02 AUD
0.00 AUD
0.00 AUD
Jan 1, 2026 (e)
0.02 AUD
0.02 AUD
0.00 AUD
Jan 1, 2027 (e)
0.00 AUD
0.04 AUD
0.00 AUD
Jan 1, 2028 (e)
0.00 AUD
0.04 AUD
0.00 AUD

Sigma Healthcare dividend payout ratio

In 2025, Sigma Healthcare had a payout ratio of 36.78%. The payout ratio indicates the percentage of the company's profits that Sigma Healthcare distributes as dividends.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Payout ratio
Details
Date
Payout ratio
Jan 1, 2021
-402.41 %
Jan 1, 2022
1,224.20 %
Jan 1, 2023
330.34 %
Jan 1, 2024
-125.81 %
Jan 1, 2025
36.78 %
Jan 1, 2026 (e)
57.31 %
Jan 1, 2027 (e)
48.34 %
Jan 1, 2028 (e)
42.27 %

Current Sigma Healthcare forecasts and price targets in July 2026

Analyst Price Targets 2026
Δ MOM Price Target
1.35 %
Buy70.59 % (12)
Hold29.41 % (5)
Sell0.00 % (0)
12M Price Target
3.46
Last Price
2.84
Currency
AUD
12M Return Potential
21.75 %
LTM Return
0 %

Sigma Healthcare Earnings Estimates

DateEPS estimateRevenue EstimateQuarterly report
3/29/20240.00AUD1.72 BAUD2024 Q4
3/22/20230.01AUD1.70 BAUD2023 Q4
9/26/20220.00AUD1.69 BAUD2023 Q2
3/29/20220.02AUD1.82 BAUD2022 Q4
9/21/20210.02AUD1.90 BAUD2022 Q2
3/23/20210.02AUD1.92 BAUD2021 Q4
9/10/20200.01AUD1.89 BAUD2021 Q2
3/25/20200.00AUD1.12 BAUD2020 Q4
9/13/20120.02AUD1.41 BAUD2013 Q2
3/22/20120.02AUD1.50 BAUD2012 Q4

EESG©

Eulerpool ESG Scorecard© for the Sigma Healthcare stock

57/100
65
Environment
73
Social
33
Governance
E

Environment

20
Scope 1 - Direct Emissions7.57
Scope 2 - Indirect emissions from purchased energy6,594
Scope 3 - Indirect emissions within the value chain—
Total CO₂ emissions6,601
CO₂ reduction strategy
Coal energy
Nuclear power
Animal experiments
Fur & Leather—
Pesticides—
Palm Oil—
Tobacco
Genetically modified organisms
Climate concept—
Sustainable forestry—
Recycling regulations
Environmentally friendly packaging
Hazardous substances
Fuel consumption and efficiency
Water consumption and efficiency
S

Social

20
Percentage of female employees64
Percentage of women in management—
Percentage of Asian employees—
Share of Asian management—
Percentage of Hispanic/Latino employees—
Hispano/Latino Management share—
Percentage of Black employees—
Black Management Share—
Percentage of white employees—
White Management Share—
Adult content
Alcohol
Weapons—
Firearms
Gambling
Military contracts
Human rights concept
Privacy concept—
Occupational health and safety
Catholic
G

Governance (Corporate Governance)

4
Environmental reporting
Stakeholder Engagement
Call Back Policies
Antitrust law

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

Sigma Healthcare shareholder structure

% Name
24.37085%
Verrocchi (Mario)
Verrocchi (Mario)
15.06010%
Gance (Jack)
Gance (Jack)
13.79936%
Gance (Sam)
Gance (Sam)
2.99270%
AV Family Foundation Pty. Ltd.
AV Family Foundation Pty. Ltd.
2.99270%
MJV Family Foundation Pty. Ltd.
MJV Family Foundation Pty. Ltd.
1.58219%
Narula (Sunil)
Narula (Sunil)
...

Sigma Healthcare Executives and Management Board

VR

Mr. Vikesh Ramsunder

(51)

Chief Executive Officer, Managing Director, Executive Director · since 2022

Compensation3.38 M AUD
MC

Mr. Mark Conway

Chief Financial Officer

Compensation486,262.00 AUD
MS

Mr. Michael Sammells

Non-Executive Chairman of the Board

Compensation461,085.00 AUD
NM

Mr. Neville Mitchell

(64)

Non-Executive Director

Compensation199,538.00 AUD
KS

Ms. Kathryn Spargo

(71)

Non-Executive Director

Compensation174,883.00 AUD

Sigma Healthcare Supply Chain

Sigma Healthcare Supply Chain

Correlation: how closely stock prices move together

Same directionNo relationOpposite
3 companies
#Name1M3M6M1Y2YTrend
1
Strides Pharma Science
Supplier
0.33
0.22
-0.32
0.81
0.64
2
CellSeed
Supplier
-0.31
-0.42
-0.43
0.74
0.63
#Name1M3M6M1Y2YTrend
1
Elanor Retail Property
Supplier
0.15
0.50
0.10
-0.50
—

Frequently asked questions about Sigma Healthcare

Sigma Healthcare Ltd operates as a leading healthcare distribution company in Australia. With a robust business model, the company focuses on providing comprehensive pharmacy services, wholesale distribution, and retail support to pharmacy customers across the nation. Sigma Healthcare aims to enhance patient health outcomes by ensuring the timely delivery of pharmaceuticals, healthcare products, and related services. By leveraging its extensive network, advanced technology, and strategic partnerships, Sigma Healthcare efficiently manages the supply chain, optimizes inventory, and assists pharmacies in delivering quality healthcare solutions. Through its customer-centric approach and commitment to innovation, Sigma Healthcare upholds its position as a trusted provider in the Australian healthcare industry.

All fundamentals and in-depth analysis of Sigma Healthcare

Our stock analysis for Sigma Healthcare stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Sigma Healthcare. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.

Sigma Healthcare Stock
Sigma Healthcare Revenue→
Sigma Healthcare Stock
Sigma Healthcare Net Income→
Sigma Healthcare Stock
Sigma Healthcare P/E→
Sigma Healthcare Stock
Sigma Healthcare P/S→
Sigma Healthcare Stock
Sigma Healthcare EBIT→
Sigma Healthcare Stock
Sigma Healthcare Dividend→
Sigma Healthcare Stock
Sigma Healthcare Directors Dealings→
Sigma Healthcare Stock
Sigma Healthcare Stocks→
Sigma Healthcare Stock
Sigma Healthcare Market capitalization→
Sigma Healthcare Stock
Sigma Healthcare Debt→
Sigma Healthcare Stock
Sigma Healthcare Liabilities→
Sigma Healthcare Stock
Sigma Healthcare Equity→
Sigma Healthcare Stock
Sigma Healthcare AAQS→
Sigma Healthcare Stock
Sigma Healthcare Employees→
Sigma Healthcare Stock
Sigma Healthcare ROE→
Sigma Healthcare Stock
Sigma Healthcare ROA→
Sigma Healthcare Stock
Sigma Healthcare ROCE→
Sigma Healthcare Stock
Sigma Healthcare News→
Sigma Healthcare Stock
Sigma Healthcare Analyst Price Targets→

Health Stocks

Sikarin PCLSight SciencesSilence TherapeuticsSigachi IndustriesSilk Laser AustraliaSIGA TechnologiesSillaJenSienna Senior LivingSilo PharmaSienna BiopharmaceuticalsSiloam International Hospitals Tbk PTSiemens HealthineersAll Stocks A–Z →